FABIANNE NORDENSON

Fabianne Nordenson serves as a distinguished Principal at Vivo Capital, a globally recognized investment firm dedicated exclusively to the healthcare sector. In this pivotal role, Ms. Nordenson is instrumental in driving the firm's investment strategy, focusing on identifying and nurturing companies poised to revolutionize healthcare and life sciences. Her work at Vivo Capital encompasses a broad spectrum of responsibilities, from rigorous due diligence and market analysis to active portfolio management and strategic support for invested companies.

Vivo Capital's investment philosophy centers on backing innovative businesses across various stages, including venture capital, growth equity, and public equity, all within the dynamic healthcare landscape. Fabianne Nordenson's expertise aligns perfectly with this mission, as she concentrates on opportunities within biotechnology, pharmaceuticals, medical devices, diagnostics, and other cutting-edge healthcare technologies. She is deeply involved in evaluating potential investments, assessing their scientific merit, market potential, and operational capabilities to ensure they meet Vivo Capital's stringent investment criteria. Her contributions are vital in shaping the firm's diverse portfolio, which aims to deliver both significant financial returns and meaningful advancements in patient care.

Prior to her tenure at Vivo Capital, Fabianne Nordenson cultivated a robust career foundation that equipped her with a comprehensive understanding of both finance and the intricacies of the healthcare industry. While specific details of her early career are often proprietary, professionals in her position typically bring backgrounds in investment banking, management consulting, or direct experience within the life sciences sector. This diverse experience provides her with a unique perspective, enabling her to critically evaluate complex scientific data, understand regulatory landscapes, and assess market dynamics with precision. Her analytical acumen and strategic insights are invaluable assets in navigating the competitive and rapidly evolving healthcare investment space.

At Vivo Capital, Ms. Nordenson collaborates closely with a team of seasoned professionals, leveraging collective expertise to identify promising ventures and guide them toward success. Her involvement extends beyond capital deployment; she often works alongside management teams, offering strategic guidance, operational support, and access to Vivo Capital's extensive network of industry experts. This hands-on approach underscores her commitment to fostering growth and innovation within the portfolio companies. Fabianne Nordenson's dedication to advancing healthcare through strategic investment reinforces Vivo Capital's reputation as a leader in the global life sciences investment community, contributing to the development of therapies and technologies that improve lives worldwide.